These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 22987155)

  • 1. [Prevention and treatment of venous thromboembolism in patients with cancer].
    Struve S; Wendtner CM
    Dtsch Med Wochenschr; 2012 Oct; 137(40):2007-9. PubMed ID: 22987155
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cancer, thromboembolia and antithrombotic therapy: is there an anticoagulant of choice?].
    Scharf RE
    Dtsch Med Wochenschr; 2011 Nov; 136(47):2403. PubMed ID: 22094968
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
    van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
    Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guideline update. VTE disease: which agents, and when.
    Holten KB; Merok J
    J Fam Pract; 2009 Mar; 58(3):E1. PubMed ID: 19284934
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term use of different doses of low-molecular-weight heparin versus vitamin K antagonists in the treatment of venous thromboembolism.
    Romera-Villegas A; Cairols-Castellote MA; Vila-Coll R; Martí-Mestre X; Colomé E; Iguaz I
    Ann Vasc Surg; 2010 Jul; 24(5):628-39. PubMed ID: 19932949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Secondary prevention of venous thromboembolism].
    Bauersachs RM
    Dtsch Med Wochenschr; 2012 Oct; 137(40):1994-7. PubMed ID: 23023608
    [No Abstract]   [Full Text] [Related]  

  • 7. [Secondary prevention of venous thromboembolism in patients with cancer].
    Meyer G
    Rev Prat; 2011 Nov; 61(9):1249-51. PubMed ID: 22308809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compliance with recommendations of clinical practice in the management of venous thromboembolism in cancer: the CARMEN study.
    Sevestre MA; Belizna C; Durant C; Bosson JL; Vedrine L; Cajfinger F; Debourdeau P; Farge D;
    J Mal Vasc; 2014 May; 39(3):161-8. PubMed ID: 24746736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of palliative low-molecular-weight heparin for treating venous thromboembolism in patients with advanced cancer.
    Tran QN
    Am J Hosp Palliat Care; 2010 Sep; 27(6):416-9. PubMed ID: 20197558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of venous thrombosis.
    Lee AY
    Cancer Treat Res; 2009; 148():243-57. PubMed ID: 19377928
    [No Abstract]   [Full Text] [Related]  

  • 11. Importance of meta-analysis of long-term trials of low-molecular-weight heparin vs vitamin K antagonist in pulmonary embolism.
    Koracevic GP
    Am J Emerg Med; 2013 Mar; 31(3):627-8. PubMed ID: 23337178
    [No Abstract]   [Full Text] [Related]  

  • 12. [Thoughts about thromboembolic events prophylaxis in cancer patients].
    Pikó B; Kremer IM; Rahoty P; Bassam A; Dimák S; Kis A; Csiffári M; Rus-Gal P; Szabó Z; Veréb B; Zsilak J
    Magy Onkol; 2011 Sep; 55(3):164-9. PubMed ID: 21918741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 8(th) American College of Chest Physicians Guidelines - a perspective on venous thromboembolism guidelines.
    Squizzato A; Ageno W
    Thromb Haemost; 2009 Jan; 101(1):31-5. PubMed ID: 19132186
    [No Abstract]   [Full Text] [Related]  

  • 14. [The optimal duration of anticoagulant treatment following pulmonary embolism].
    Couturaud F
    Rev Mal Respir; 2011 Dec; 28(10):1265-77. PubMed ID: 22152935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An open-label comparison of the efficacy and safety of certoparin versus unfractionated heparin for the prevention of thromboembolic complications in acutely ill medical patients: CERTAIN.
    Schellong SM; Haas S; Greinacher A; Schwanebeck U; Sieder C; Abletshauser C; Bramlage P; Riess H
    Expert Opin Pharmacother; 2010 Dec; 11(18):2953-61. PubMed ID: 20950224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention and treatment of venous thromboembolism in pregnancy.
    James AH
    Clin Obstet Gynecol; 2012 Sep; 55(3):774-87. PubMed ID: 22828110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulant use in cancer patients.
    Trujillo-Santos J; Monreal M
    Expert Opin Pharmacother; 2011 Feb; 12(3):351-62. PubMed ID: 21254944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of Cancer-Associated Venous Thromboembolism in the Emergency Department.
    Nene RV; Coyne CJ
    Ann Emerg Med; 2017 Jun; 69(6):768-776. PubMed ID: 28169053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of deep vein thrombosis in cancer patients.
    Lee AY
    Semin Thromb Hemost; 2007 Oct; 33(7):699-706. PubMed ID: 18000798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Internist patients are strongly thrombosis endangered. CERTIFY study has arrived].
    MMW Fortschr Med; 2007 May; 149(20):52-3. PubMed ID: 18051966
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.